Announcements Trials

Browse Landscape

Phase

Status

Completed 3 Recruiting 1 Active not recruiting 1

Sponsor Class

OTHER 3 INDUSTRY 3 NIH 2 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 19 Multiple Myeloma 16 Prostatic Neoplasms 14 Carcinoma, Non-Small-Cell Lung 12 Neoplasms 10 Precursor Cell Lymphoblastic Leukemia-Lymphoma 9 Lymphoma 9 Leukemia, Myeloid, Acute 7 Lung Neoplasms 6 Leukemia, Biphenotypic, Acute 6 Squamous Cell Carcinoma of Head and Neck 5 Neuroblastoma 5 Medulloblastoma 5 Lymphoma, Mantle-Cell 5 Leukemia 5 Hodgkin Disease 5 Ependymoma 5 Colorectal Neoplasms 5 Oropharyngeal Neoplasms 4 Neoplasm Metastasis 4 Myelodysplastic Syndromes 4 Leukemia, Myeloid, Chronic-Phase 4 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 4 Burkitt Lymphoma 4 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3 Oligodendroglioma 3 Melanoma 3 Leukemia, Lymphocytic, Chronic, B-Cell 3 Hematologic Neoplasms 3 Glioma 3

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × NETWORK × Thymoma × Clear all

NCT03134118 2026-05-15

NIVOTHYM

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Active not recruiting

Thymoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡